• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管内介入治疗在糖尿病慢性肢体威胁性缺血患者外周动脉疾病中的作用

The Role of Endovascular Procedure for Peripheral Arterial Disease in Diabetic Patients With Chronic Limb-Threatening Ischemia.

作者信息

Santosa Yudistira, Harca Azizah Dhena, Sukmaja Edwin, Yuwono Angelina

机构信息

Department of Internal Medicine, School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, IDN.

General Medicine, Primaya Hospital, Jakarta, IDN.

出版信息

Cureus. 2022 Apr 5;14(4):e23857. doi: 10.7759/cureus.23857. eCollection 2022 Apr.

DOI:10.7759/cureus.23857
PMID:35530835
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9072076/
Abstract

Type 2 diabetes mellitus is a major risk factor for all forms of cardiovascular diseases, including peripheral arterial disease (PAD). Chronic limb-threatening ischemia (CLTI) is determined by the presence of ischemic rest pain, and may or may not be accompanied by tissue loss (such as ulcers and gangrene) or infection. Treatments for CLTI consist of wound treatment, infection control, and ischemia control by arterial revascularization, which can be performed by either open surgical procedure (bypass) or an endovascular approach. We present two cases of chronic limb-threatening ischemia, one with an above-knee lesion and the other with a below-knee lesion. In addition to good wound treatment and glucose control as the risk factor management, we performed endovascular therapy in both patients. Both patients showed good wound improvement after the procedure.

摘要

2型糖尿病是包括外周动脉疾病(PAD)在内的所有形式心血管疾病的主要危险因素。慢性肢体威胁性缺血(CLTI)由缺血性静息痛确定,可能伴有或不伴有组织缺失(如溃疡和坏疽)或感染。CLTI的治疗包括伤口处理、感染控制以及通过动脉血运重建控制缺血,动脉血运重建可通过开放手术(搭桥)或血管内介入方法进行。我们展示了两例慢性肢体威胁性缺血病例,一例为膝上病变,另一例为膝下病变。除了作为危险因素管理的良好伤口处理和血糖控制外,我们对两名患者均进行了血管内治疗。术后两名患者的伤口均有明显改善。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73a5/9072076/012f53351982/cureus-0014-00000023857-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73a5/9072076/374cf7468f67/cureus-0014-00000023857-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73a5/9072076/38d7aed51a1b/cureus-0014-00000023857-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73a5/9072076/c0ab81824487/cureus-0014-00000023857-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73a5/9072076/343cbad509c5/cureus-0014-00000023857-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73a5/9072076/92775f172126/cureus-0014-00000023857-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73a5/9072076/012f53351982/cureus-0014-00000023857-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73a5/9072076/374cf7468f67/cureus-0014-00000023857-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73a5/9072076/38d7aed51a1b/cureus-0014-00000023857-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73a5/9072076/c0ab81824487/cureus-0014-00000023857-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73a5/9072076/343cbad509c5/cureus-0014-00000023857-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73a5/9072076/92775f172126/cureus-0014-00000023857-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73a5/9072076/012f53351982/cureus-0014-00000023857-i06.jpg

相似文献

1
The Role of Endovascular Procedure for Peripheral Arterial Disease in Diabetic Patients With Chronic Limb-Threatening Ischemia.血管内介入治疗在糖尿病慢性肢体威胁性缺血患者外周动脉疾病中的作用
Cureus. 2022 Apr 5;14(4):e23857. doi: 10.7759/cureus.23857. eCollection 2022 Apr.
2
Effectiveness of combined superficial femoral artery endovascular therapy with popliteal-to-distal bypass: A paradigm shift in surgical open bypass for chronic limb-threatening ischemia.股浅动脉腔内治疗联合腘动脉至远端旁路移植术的有效性:慢性肢体威胁性缺血手术开放旁路移植术的范式转变。
Vascular. 2021 Dec;29(6):905-912. doi: 10.1177/1708538120981224. Epub 2020 Dec 21.
3
Surgical and Endovascular Therapies for Below-the-Knee Peripheral Arterial Disease: A Contemporary Review.膝下外周动脉疾病的手术及血管内治疗:当代综述
J Soc Cardiovasc Angiogr Interv. 2024 Jan 29;3(3Part A):101268. doi: 10.1016/j.jscai.2023.101268. eCollection 2024 Mar.
4
Mesenchymal stem cell-based therapy for non-healing wounds due to chronic limb-threatening ischemia: A review of preclinical and clinical studies.基于间充质干细胞的疗法治疗慢性肢体威胁性缺血所致难愈性伤口:临床前和临床研究综述
Front Cardiovasc Med. 2023 Feb 1;10:1113982. doi: 10.3389/fcvm.2023.1113982. eCollection 2023.
5
Contemporary treatment of below-the-knee peripheral arterial disease in patients with chronic limb threatening ischemia: Observations from the Vascular Quality Initiative.慢性肢体威胁性缺血患者膝下周围动脉疾病的当代治疗:来自血管质量倡议的观察结果
Catheter Cardiovasc Interv. 2022 Mar;99(4):1289-1299. doi: 10.1002/ccd.30063. Epub 2022 Jan 23.
6
Early and eighteen month clinical outcomes of first UK case of percutaneous deep vein arterialisation (pDVA) to treat "no option" chronic limb-threatening ischemia using the LimFlow system.英国首例使用LimFlow系统进行经皮深静脉动脉化(pDVA)治疗“无其他选择”的慢性肢体威胁性缺血的早期及18个月临床结果。
CVIR Endovasc. 2021 Aug 9;4(1):62. doi: 10.1186/s42155-021-00252-4.
7
Survival prediction in patients with chronic limb-threatening ischemia who undergo infrainguinal revascularization.慢性肢体严重缺血患者行下肢血运重建术后的生存预测。
Eur J Vasc Endovasc Surg. 2019 Jul;58(1S):S120-S134.e3. doi: 10.1016/j.ejvs.2019.04.009. Epub 2019 May 28.
8
Complex multilevel and multivessel endovascular revascularization through an occluded femoral-popliteal bypass in a patient with chronic limb threatening ischemia.通过闭塞的股腘动脉旁路对一名患有慢性肢体威胁性缺血的患者进行复杂的多级和多血管腔内血管重建术。
J Vasc Bras. 2022 Jan 17;21:e20210057. doi: 10.1590/1677-5449.210057. eCollection 2022.
9
Association between omentin-1 and major cardiovascular events after lower extremity endovascular revascularization in diabetic patients: a prospective cohort study.在糖尿病患者下肢血管腔内再通术后,网膜素-1 与主要心血管事件的关系:一项前瞻性队列研究。
Cardiovasc Diabetol. 2020 Oct 7;19(1):170. doi: 10.1186/s12933-020-01151-z.
10
A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.经系统回顾和荟萃分析的肢体严重缺血性慢性下肢动脉疾病血运重建结局。
J Vasc Surg. 2019 Jun;69(6S):126S-136S. doi: 10.1016/j.jvs.2018.01.071. Epub 2019 May 28.

引用本文的文献

1
Artificial Intelligence Methodologies Applied to Technologies for Screening, Diagnosis and Care of the Diabetic Foot: A Narrative Review.人工智能方法在糖尿病足筛查、诊断和护理技术中的应用:叙事性综述。
Biosensors (Basel). 2022 Nov 8;12(11):985. doi: 10.3390/bios12110985.

本文引用的文献

1
Epidemiology of Peripheral Artery Disease and Polyvascular Disease.外周动脉疾病和多血管疾病的流行病学。
Circ Res. 2021 Jun 11;128(12):1818-1832. doi: 10.1161/CIRCRESAHA.121.318535. Epub 2021 Jun 10.
2
Outcomes of Lower Extremity Endovascular Revascularization: Potential Predictors and Prevention Strategies.下肢血管腔内血管重建的结果:潜在的预测因素和预防策略。
Int J Mol Sci. 2021 Feb 18;22(4):2002. doi: 10.3390/ijms22042002.
3
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS).
2017年欧洲心脏病学会(ESC)与欧洲血管外科学会(ESVS)合作制定的外周动脉疾病诊断和治疗指南:涵盖颅外颈动脉和椎动脉、肠系膜、肾、上肢和下肢动脉粥样硬化疾病的文件 认可机构:欧洲卒中组织(ESO) 欧洲心脏病学会(ESC)和欧洲血管外科学会(ESVS)外周动脉疾病诊断和治疗特别工作组
Eur Heart J. 2018 Mar 1;39(9):763-816. doi: 10.1093/eurheartj/ehx095.
4
The natural history of untreated severe or critical limb ischemia.未经治疗的严重或危急肢体缺血的自然病程。
J Vasc Surg. 2015 Dec;62(6):1642-51.e3. doi: 10.1016/j.jvs.2015.07.065. Epub 2015 Sep 26.
5
Peripheral artery disease in patients with diabetes: Epidemiology, mechanisms, and outcomes.糖尿病患者外周动脉疾病:流行病学、发病机制和结局。
World J Diabetes. 2015 Jul 10;6(7):961-9. doi: 10.4239/wjd.v6.i7.961.
6
The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society.血管生物标志物在一级和二级预防中的作用。欧洲心脏病学会外周循环工作组的立场文件:得到动脉结构和生理学研究协会(ARTERY 协会)的认可。
Atherosclerosis. 2015 Aug;241(2):507-32. doi: 10.1016/j.atherosclerosis.2015.05.007. Epub 2015 May 16.
7
Epidemiology of peripheral artery disease.外周动脉疾病的流行病学。
Circ Res. 2015 Apr 24;116(9):1509-26. doi: 10.1161/CIRCRESAHA.116.303849.
8
The BEST-CLI trial: a multidisciplinary effort to assess whether surgical or endovascular therapy is better for patients with critical limb ischemia.最佳下肢缺血血管重建术(BEST-CLI)试验:一项多学科协作的研究,旨在评估手术治疗或血管内治疗对严重肢体缺血患者哪种效果更佳。
Semin Vasc Surg. 2014 Mar;27(1):82-4. doi: 10.1053/j.semvascsurg.2015.01.003. Epub 2015 Jan 22.
9
Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial.药物涂层球囊与标准球囊血管成形术治疗临界肢体缺血的腘动脉血运重建:来自 IN.PACT DEEP 随机试验的 12 个月结果。
J Am Coll Cardiol. 2014 Oct 14;64(15):1568-76. doi: 10.1016/j.jacc.2014.06.1198.
10
Diagnosis and treatment of peripheral arterial disease in diabetic patients with a foot ulcer. A progress report of the International Working Group on the Diabetic Foot.糖尿病足溃疡患者外周动脉疾病的诊断与治疗。国际糖尿病足工作组进展报告。
Diabetes Metab Res Rev. 2012 Feb;28 Suppl 1:218-24. doi: 10.1002/dmrr.2255.